Mary J. Ruwart

1.5k total citations
64 papers, 1.3k citations indexed

About

Mary J. Ruwart is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Mary J. Ruwart has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Mary J. Ruwart's work include Neuropeptides and Animal Physiology (11 papers), Drug Transport and Resistance Mechanisms (11 papers) and Inflammatory mediators and NSAID effects (11 papers). Mary J. Ruwart is often cited by papers focused on Neuropeptides and Animal Physiology (11 papers), Drug Transport and Resistance Mechanisms (11 papers) and Inflammatory mediators and NSAID effects (11 papers). Mary J. Ruwart collaborates with scholars based in United States, Australia and Poland. Mary J. Ruwart's co-authors include B.D. Rush, Bob D. Rush, M.S. Klepper, Karen F. Wilkinson, N.M. Friedle, Jed F. Fisher, Montford F. Piercey, Thomas J. Vidmar, Allen W. Harrison and Clarence H. Suelter and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Mary J. Ruwart

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary J. Ruwart United States 21 371 263 236 201 187 64 1.3k
K.‐Fr. Sewing Germany 24 666 1.8× 310 1.2× 434 1.8× 690 3.4× 71 0.4× 101 2.3k
J. B. Meddings Canada 21 405 1.1× 73 0.3× 92 0.4× 444 2.2× 94 0.5× 32 1.4k
Andreas Schwab Canada 21 303 0.8× 201 0.8× 279 1.2× 114 0.6× 110 0.6× 42 1.1k
Alison E.M. Vickers United States 23 443 1.2× 503 1.9× 330 1.4× 197 1.0× 219 1.2× 55 1.5k
Isao Yamatsu Japan 14 258 0.7× 136 0.5× 72 0.3× 102 0.5× 74 0.4× 51 834
Seiji Morisawa Japan 22 1.2k 3.3× 275 1.0× 200 0.8× 216 1.1× 273 1.5× 201 2.2k
Leon L. Miller United States 26 866 2.3× 137 0.5× 152 0.6× 427 2.1× 121 0.6× 76 2.5k
Michael R. Krout United States 12 763 2.1× 98 0.4× 318 1.3× 187 0.9× 87 0.5× 17 2.1k
John G. Harter United States 16 214 0.6× 302 1.1× 152 0.6× 69 0.3× 65 0.3× 29 1.3k
Keith Hoffmaster United States 16 298 0.8× 409 1.6× 625 2.6× 113 0.6× 141 0.8× 20 1.4k

Countries citing papers authored by Mary J. Ruwart

Since Specialization
Citations

This map shows the geographic impact of Mary J. Ruwart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary J. Ruwart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary J. Ruwart more than expected).

Fields of papers citing papers by Mary J. Ruwart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary J. Ruwart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary J. Ruwart. The network helps show where Mary J. Ruwart may publish in the future.

Co-authorship network of co-authors of Mary J. Ruwart

This figure shows the co-authorship network connecting the top 25 collaborators of Mary J. Ruwart. A scholar is included among the top collaborators of Mary J. Ruwart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary J. Ruwart. Mary J. Ruwart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruwart, Mary J.. (1997). Update. Drug Discovery Today. 2(1). 5–5. 1 indexed citations
2.
Islam, Imadul, K. T. Chong, T. J. MCQUADE, et al.. (1994). Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors. Journal of Medicinal Chemistry. 37(2). 293–304. 10 indexed citations
3.
Martin, L. N., Kenneth F. Soike, Michael Murphey‐Corb, et al.. (1994). Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys. Antimicrobial Agents and Chemotherapy. 38(6). 1277–1283. 19 indexed citations
4.
Harrison, Allen W., Mary J. Ruwart, Karen F. Wilkinson, et al.. (1993). Evaluation of the Bile Acid Transporter in Enhancing Intestinal Permeability to Renin-Inhibitory Peptides. Journal of drug targeting. 1(4). 347–359. 24 indexed citations
5.
Wilkinson, Karen F., Bob D. Rush, Satish Kumar Sharma, et al.. (1993). Development of Activity Assays for High-Volume Evaluation of Human Immunodeficiency Virus (HIV) Protease Inhibitors in Rat Serum: Results with Ditekiren. Pharmaceutical Research. 10(4). 562–566. 2 indexed citations
6.
Conradi, Robert A., Karen F. Wilkinson, Bob D. Rush, et al.. (1993). In Vitro/in Vivo Models for Peptide Oral Absorption: Comparison of Caco-2 Cell Permeability with Rat Intestinal Absorption of Renin Inhibitory Peptides. Pharmaceutical Research. 10(12). 1790–1792. 44 indexed citations
7.
Ruwart, Mary J., Roger R. Hinshaw, Karen F. Wilkinson, et al.. (1993). Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities. Journal of Medicinal Chemistry. 36(17). 2575–2577. 23 indexed citations
8.
Fisher, Jed F., Allen W. Harrison, Gordon L. Bundy, et al.. (1991). Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties. Journal of Medicinal Chemistry. 34(10). 3140–3143. 91 indexed citations
9.
Pollak, Raymond, et al.. (1991). An in vitro comparison of the immunosuppressive potential of synthetic prostaglandin analogues.. PubMed. 23(1 Pt 1). 346–7. 1 indexed citations
10.
Ruwart, Mary J., Satish Kumar Sharma, Douglas W. Harris, et al.. (1990). Development of a Sensitive Activity Assay for High-Volume Evaluation of Human Renin Inhibitory Peptides in Rat Serum: Results with U-71,038. Pharmaceutical Research. 7(4). 407–410. 7 indexed citations
11.
Ruwart, Mary J., Karen F. Wilkinson, Bob D. Rush, et al.. (1989). The Integrated Value of Serum Procollagen Iii Peptide Over Time Predicts Hepatic Hydroxyproline Content and Stainable Collagen in A Model of Dietary Cirrhosis in the Rat. Hepatology. 10(5). 801–806. 87 indexed citations
12.
Pollak, Raymond, et al.. (1989). Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen.. PubMed. 21(5). 3769–70. 1 indexed citations
13.
Peters, Kenneth M., et al.. (1989). 16, 16 Dimethyl prostaglandin E2 decreases the formation of collagen in fibrotic rat liver slices. Prostaglandins. 37(4). 445–456. 8 indexed citations
14.
Ruwart, Mary J., et al.. (1988). 16,16-dimethyl prostaglandin E2 delays collagen formation in nutritional injury in rat liver†. Hepatology. 8(1). 61–64. 50 indexed citations
15.
16.
Gilbertson, Terry J., Mary J. Ruwart, R.P. Stryd, et al.. (1983). Partial characterization of the gastrointestinal weight changes produced in the female rat by 16,16-dimethylprostaglandin E2. Prostaglandins. 26(5). 745–759. 21 indexed citations
17.
Ruwart, Mary J., M.S. Klepper, & Bob D. Rush. (1980). Adrenergic and cholinergic contributions to decreased gastric emptying, small intestinal transit, and colonic transit in the postoperative ileus rat. Journal of Surgical Research. 29(2). 126–134. 13 indexed citations
18.
Ruwart, Mary J., D. L. Kaminski, & John W. Hahn. (1979). Secretin-, glucagon-, and insulin-induced effects on bile flow and metabolism of isolated perfused canine and porcine liver. Journal of Surgical Research. 26(6). 674–680. 7 indexed citations
19.
Ruwart, Mary J., M.S. Klepper, & B.D. Rush. (1978). The beneficial effects of prostaglandins in post-operative ileus. Gastroenterology. 74(5). 1088–1088. 2 indexed citations
20.
Kaminski, D. L., et al.. (1977). The effect of prostaglandin F2α on canine hepatic bile flow and biliary cyclic AMP secretion. Journal of Surgical Research. 22(5). 545–553. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.‐Fr. Sewing Breakdown of academic impact, for papers by J. B. Meddings Breakdown of academic impact, for papers by Andreas Schwab Breakdown of academic impact, for papers by Alison E.M. Vickers Breakdown of academic impact, for papers by Isao Yamatsu Breakdown of academic impact, for papers by Seiji Morisawa Breakdown of academic impact, for papers by Leon L. Miller Breakdown of academic impact, for papers by Michael R. Krout Breakdown of academic impact, for papers by John G. Harter Breakdown of academic impact, for papers by Keith Hoffmaster
Rankless by CCL
2026